GlassScriptPhysician profile
Christopher L Ingram
NPI 1366432718
$3,924.07
in general payments reported to CMS, 2019-2025
21 companies · $340 in 2025
The $340 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $908 · 2020: $717 · 2021: $818 · 2022: $576 · 2023: $289 · 2024: $278 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $906.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $632.09 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $518.07 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $488.28 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $313.16 | 2021-2025 | Verquvo |
| Abbott Laboratories | $302.77 | 2019-2022 | |
| Astellas Pharma US INC | $289.47 | 2019-2021 | |
| Pfizer INC. | $266.26 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $244.59 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $235.55 | 2019-2024 | Camzyos |
| Janssen Pharmaceuticals, INC | $156.07 | 2019-2022 | |
| Amgen INC. | $65.75 | 2020-2023 | Repatha |
| Inspire Medical Systems, INC. | $64.17 | 2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $57.70 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $57.23 | 2020-2022 | |
| Ge Healthcare | $46.31 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $46.28 | 2023-2025 | |
| Novo Nordisk INC | $44.29 | 2025 | Wegovy |
| Kestra Medical Technology Services, INC. | $34.54 | 2025 | Assure Wcd |
| Kowa Pharmaceuticals America, INC. | $31.35 | 2019 | |
| Itamar Medical INC | $15.16 | 2023 | Watchpatone |
| Lexicon Pharmaceuticals, INC. | $14.98 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ingram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.